Adeno-associated virus serotypes: Vector toolkit for human gene therapy

被引:655
作者
Wu, Zhijian [1 ]
Asokan, Aravind [1 ]
Samulski, R. Jude [1 ]
机构
[1] Univ N Carolina, Sch Med, Gene Therapy Ctr, Chapel Hill, NC 27599 USA
关键词
adeno-associated virus; serotype; tropism; vector; hybrid;
D O I
10.1016/j.ymthe.2006.05.009
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Recombinant adeno-associated viral (AAV) vectors have rapidly advanced to the forefront of gene therapy in the past decade. The exponential progress of AAV-based vectors has been made possible by the isolation of several naturally occurring AAV serotypes and over 100 AAV variants from different animal species. These isolates are ideally suited to development into human gene therapy vectors due to their diverse tissue tropisms and potential to evade preexisting neutralizing antibodies against the common human AAV serotype 2. Despite their prolific application in several animal models of disease, the mechanisms underlying selective tropisms of AAV serotypes remain largely unknown. Efforts to understand cell surface receptor usage and intracellular trafficking pathways exploited by AAV continue to provide significant insight into the biology of AAV vectors. Such unique traits are thought to arise from differences in surface topology of the capsids of AAV serotypes and variants. In addition to the aforementioned naturally evolved AAV isolates, several strategies to engineer hybrid AAV serotype vectors have been formulated in recent years. The generation of mosaic or chimeric vectors through the transcapsiclation or marker-rescue/domain-swapping approach, respectively, is notable in this regard. More recently, combinatorial strategies for engineering AAV vectors using error-prone PCR, DNA shuffling, and other molecular cloning techniques have been established. The latter library-based approaches can serve as powerful tools in the generation of low-immunogenic and cell/tissue type-specific AAV vectors for gene delivery. This review is focused on recent developments in the isolation of novel AAV serotypes and isolates, their production and purification, diverse tissue tropisms, mechanisms of cellular entry/trafficking, and capsid structure. Strategies for engineering hybrid AAV vectors derived from AAV serotypes and potential implications of the rapidly expanding AAV vector toolkit are discussed.
引用
收藏
页码:316 / 327
页数:12
相关论文
共 129 条
[1]   Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors [J].
Alisky, JM ;
Hughes, SM ;
Sauter, SL ;
Jolly, D ;
Dubensky, TW ;
Staber, PD ;
Chiorini, JA ;
Davidson, BL .
NEUROREPORT, 2000, 11 (12) :2669-2673
[2]   Novel caprine adeno-associated virus (AAV) capsid (AAV-Go.1) is closely related to the primate AAV-5 and has unique tropism and neutralization properties [J].
Arbetman, AE ;
Lochrie, M ;
Zhou, SZ ;
Wellman, J ;
Scallan, C ;
Doroudchi, MM ;
Randlev, B ;
Patarroyo-White, S ;
Liu, TY ;
Smith, P ;
Lehmkuhl, H ;
Hobbs, LA ;
Pierce, GF ;
Colosi, P .
JOURNAL OF VIROLOGY, 2005, 79 (24) :15238-15245
[3]  
ARNOLD GS, IN PRESS MOL THER
[4]   ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES [J].
ATCHISON, RW ;
CASTO, BC ;
HAMMON, WM .
SCIENCE, 1965, 149 (3685) :754-&
[5]   A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors [J].
Auricchio, A ;
O'Connor, E ;
Hildinger, M ;
Wilson, JM .
MOLECULAR THERAPY, 2001, 4 (04) :372-374
[6]   Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column [J].
Auricchio, A ;
Hildinger, M ;
O'Connor, E ;
Gao, GP ;
Wilson, JM .
HUMAN GENE THERAPY, 2001, 12 (01) :71-76
[7]   Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the Golgi compartment [J].
Bantel-Schaal, U ;
Hub, B ;
Kartenbeck, J .
JOURNAL OF VIROLOGY, 2002, 76 (05) :2340-2349
[8]   CHARACTERIZATION OF THE DNA OF A DEFECTIVE HUMAN PARVOVIRUS ISOLATED FROM A GENITAL SITE [J].
BANTELSCHAAL, U ;
HAUSEN, HZ .
VIROLOGY, 1984, 134 (01) :52-63
[9]   Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors [J].
Bartlett, JS ;
Wilcher, R ;
Samulski, RJ .
JOURNAL OF VIROLOGY, 2000, 74 (06) :2777-2785
[10]  
BLACKLOW NR, 1968, J NATL CANCER I, V40, P319